Lupin goes up as company reveals pact to acquire two inhalation brands from Sunovion
- Hot Stocks
admin
- 0
- 1 minute read
The global pharmaceutical major will acquire all rights to Brovana (arformoterol tartrate) Inhalation Solution and Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol for $75 million.
:max_bytes(150000):strip_icc():format(jpeg)/INV_PrivateCredit_GettyImages-1374879082-ec2de320ad9d4d2eab8146667dc16624.jpg "Small Business Financing: Debt or Equity?")
:max_bytes(150000):strip_icc():format(jpeg)/CanaHomeEquityLoanEnterForeclosure-8f8bcdaf7418472d92ace14057730f9c.jpg "Can a Home Equity Loan Enter Foreclosure?")
:max_bytes(150000):strip_icc():format(jpeg)/rothconversion-6f41f06aa7ae4425bb53ac3116db6906.jpg "Roth IRA Conversion: How It Works, Plus the Pros and Cons")